Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Microscopically positive margins for primary gastrointestinal stromal tumors: analysis of risk factors and tumor recurrence.

McCarter MD, Antonescu CR, Ballman KV, Maki RG, Pisters PW, Demetri GD, Blanke CD, von Mehren M, Brennan MF, McCall L, Ota DM, DeMatteo RP; American College of Surgeons Oncology Group (ACOSOG) Intergroup Adjuvant Gist Study Team.

J Am Coll Surg. 2012 Jul;215(1):53-9; discussion 59-60. doi: 10.1016/j.jamcollsurg.2012.05.008.

2.

Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group.

Diehl KM, Green EM, Weinberg A, Frederick WA, Holmes DR, Green B, Morris A, Kuerer HM, Beltran RA, Mendez J, Gines V, Ota DM, Nelson H, Newman LA.

Ann Surg Oncol. 2011 Dec;18(13):3544-50. doi: 10.1245/s10434-011-1818-9. Epub 2011 Jun 17.

3.

American College of Surgeons Oncology Group and the community surgeon.

Ota DM, Leitch AM, Unzeitig G.

Surg Oncol Clin N Am. 2011 Jul;20(3):439-45, vii. doi: 10.1016/j.soc.2011.01.006. Review.

4.

Changing multidisciplinary cancer treatment through ACOSOG trials.

Ota DM, Nelson H.

Bull Am Coll Surg. 2010 Apr;95(4):38-40. No abstract available.

PMID:
21456432
5.

Promoting patient safety through peer review.

Wilke LG, Nelson H, Ota DM.

Bull Am Coll Surg. 2010 Mar;95(3):45-6. No abstract available.

PMID:
21456407
6.

Node biopsy vs. full lymph node dissection for breast cancer.

Ota DM, Nelson H, Giuliano A.

Bull Am Coll Surg. 2010 Oct;95(10):58-9. No abstract available.

PMID:
21449281
7.

The audit process and how to ensure a successful audit.

You YN, Jacobs L, Martinez E, Ota DM.

Cancer Treat Res. 2007;132:179-97. Review. No abstract available.

PMID:
17305022
8.

Local excision of rectal cancer revisited: ACOSOG protocol Z6041.

Ota DM, Nelson H; ACOSOG Group Co-Chairs.

Ann Surg Oncol. 2007 Feb;14(2):271. Epub 2006 Nov 14. No abstract available.

PMID:
17103255
9.

Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology Group.

You YN, Jacobs L, Martinez ED, Budinger SC, Wittlief EJ, Myles SK, Ota DM; American College of Surgeons Oncology Group.

J Am Coll Surg. 2006 Sep;203(3):269-76. Epub 2006 Jul 13.

PMID:
16931297
10.

Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group.

You YN, Hunt KK, Posner MC, Putnam JB Jr, Nelson H, Ota DM, Pisters PW.

Surgery. 2006 Apr;139(4):455-9. No abstract available.

PMID:
16627052
11.

Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.

Lin KM, Patel TH, Ray A, Ota M, Jacobs L, Kuvshinoff B, Chung M, Watson M, Ota DM.

J Am Coll Surg. 2004 Oct;199(4):561-6. Review.

PMID:
15454139
12.

Hereditary nonpolyposis colorectal cancer: preventive management.

Annie Yu HJ, Lin KM, Ota DM, Lynch HT.

Cancer Treat Rev. 2003 Dec;29(6):461-70. Review.

PMID:
14585257
13.

What's new in general surgery: surgical oncology.

Ota DM.

J Am Coll Surg. 2003 Jun;196(6):926-32. Review. No abstract available.

PMID:
12788430
14.

Rectal cancer: the sphincter-sparing approach.

Ota DM, Jacobs L, Kuvshinoff B.

Surg Clin North Am. 2002 Oct;82(5):983-93. Review.

PMID:
12507204
15.

Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.

Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota DM, Lugering N, Domschke W, Binion DG.

J Biol Chem. 2003 Mar 7;278(10):8508-15. Epub 2002 Dec 20.

16.

Radiofrequency ablation of liver tumors: influence of technique and tumor size.

Kuvshinoff BW, Ota DM.

Surgery. 2002 Oct;132(4):605-11; discussion 611-2.

PMID:
12407343
17.

The sentinel node in colorectal carcinoma. Mapping technique, pathologic assessment, and clinical relevance.

Lin KM, Rodriguez F, Ota DM.

Oncology (Williston Park). 2002 May;16(5):567-75, 580; discussion 580, 582, 585. Review.

18.

Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancer.

Bold RJ, Ota DM, Ajani JA, Mansfield PF.

Gastric Cancer. 1999 May;2(1):1-7.

PMID:
11957063
19.
20.

A pilot study of preoperative chemoradiation for gastric cancer.

Ota DM.

Ann Surg Oncol. 2001 Jul;8(6):482-3. No abstract available.

PMID:
11456047
21.

Laparoscopic colectomy for cancer: an oncologic feasible option.

Lin KM, Ota DM.

Surg Oncol. 2000 Nov;9(3):127-34. Review.

PMID:
11356341
22.

Is intraoperative lymph node mapping and sentinel lymph node biopsy for colorectal carcinoma necessary?

Ota DM.

Ann Surg Oncol. 2000 Mar;7(2):82-4. No abstract available.

PMID:
10761784
23.

Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma.

Ajani JA, Mansfield PF, Lynch PM, Pisters PW, Feig B, Dumas P, Evans DB, Raijman I, Hargraves K, Curley S, Ota DM.

J Clin Oncol. 1999 Aug;17(8):2403-11.

PMID:
10561303
24.

Myocutaneous pedicle flaps after abdomino-perineal resection for recurrent rectal cancer.

Ota DM.

Ann Surg Oncol. 1999 Jan-Feb;6(1):3. No abstract available.

PMID:
10030404
25.

Clinical, pathologic, and economic parameters of laparoscopic colon resection for cancer.

Bouvet M, Mansfield PF, Skibber JM, Curley SA, Ellis LM, Giacco GG, Madary AR, Ota DM, Feig BW.

Am J Surg. 1998 Dec;176(6):554-8.

PMID:
9926789
26.

Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma.

Lieber KA, Standiford SB, Kuvshinoff BW, Ota DM.

Surgery. 1998 Oct;124(4):757-61; discussion 761-2.

PMID:
9780998
27.

Colon cancer.

Ota DM.

Cancer Treat Res. 1997;90:347-56. Review. No abstract available.

PMID:
9367092
28.

Preoperative radiotherapy for rectal cancer: benefits and controversies.

Ota DM.

Ann Surg Oncol. 1996 Sep;3(5):419-20. No abstract available.

PMID:
8876881
29.

Laparoscopic resection for colon cancer: a favorable view.

Ota DM.

Important Adv Oncol. 1996:227-9. Review. No abstract available.

PMID:
8791138
30.

Laparoscopic colon resection for cancer--a favorable view.

Ota DM.

Adv Surg. 1996;29:141-53. Review. No abstract available.

PMID:
8720000
31.

Laparoscopic colon resection for cancer.

Ota DM.

Surg Endosc. 1995 Dec;9(12):1318-22. No abstract available.

PMID:
8629219
32.

Preoperative infusional chemoradiation and surgery with or without an electron beam intraoperative boost for advanced primary rectal cancer.

Weinstein GD, Rich TA, Shumate CR, Skibber JM, Cleary KR, Ajani JA, Ota DM.

Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):197-204.

PMID:
7721616
33.

Potentially resectable gastric carcinoma: current approaches to staging and preoperative therapy.

Ajani JA, Mansfield PF, Ota DM.

World J Surg. 1995 Mar-Apr;19(2):216-20. Review.

PMID:
7754626
34.
35.

Laparoscopic colectomy for cancer: a favorable opinion.

Ota DM.

Ann Surg Oncol. 1995 Jan;2(1):3-5. No abstract available.

PMID:
7834451
36.

Complications and failures of subclavian-vein catheterization.

Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM.

N Engl J Med. 1994 Dec 29;331(26):1735-8.

37.

Pharmacologic intervention can reestablish baseline hemodynamic parameters during laparoscopy.

Feig BW, Berger DH, Dougherty TB, Dupuis JF, Hsi B, Hickey RC, Ota DM.

Surgery. 1994 Oct;116(4):733-9; discussion 739-41.

PMID:
7940173
38.

Laparoscopic-assisted segmental colectomy: surgical techniques.

Elftmann TD, Nelson H, Ota DM, Pemberton JH, Beart RW Jr.

Mayo Clin Proc. 1994 Sep;69(9):825-33. Review.

PMID:
8065183
39.

Laparoscopic intracorporeal harvest of jejunal tissue for autologous transplantation.

Staley CA, Miller M, King TJ, Clem M, Ota DM.

Surg Laparosc Endosc. 1994 Jun;4(3):192-5.

PMID:
8044361
40.

Laparoscopic intestinal stomas.

Fuhrman GM, Ota DM.

Dis Colon Rectum. 1994 May;37(5):444-9.

PMID:
8181405
41.

Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma.

Meterissian S, Skibber J, Rich T, Roubein L, Ajani J, Cleary K, Ota DM.

Ann Surg Oncol. 1994 Mar;1(2):111-6.

PMID:
7834435
42.

Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid.

Mak AC, Rich TA, Schultheiss TE, Kavanagh B, Ota DM, Romsdahl MM.

Int J Radiat Oncol Biol Phys. 1994 Feb 1;28(3):597-603.

PMID:
8113102
43.

MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T.

Gastroenterology. 1994 Feb;106(2):353-61.

PMID:
7905449
44.

Controversies regarding laparoscopic colectomy for malignant diseases.

Ota DM, Nelson H, Weeks JC.

Curr Opin Gen Surg. 1994:208-13. Review.

PMID:
7583971
45.

Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.

Ajani JA, Mayer RJ, Ota DM, Steele GD, Evans D, Roh M, Sugarbaker DJ, Dumas P, Gray C, Vena DA, et al.

J Natl Cancer Inst. 1993 Nov 17;85(22):1839-44.

PMID:
8230264
46.

Glutamine stability in biological tissues evaluated by fluorometric analysis.

Grossie VB Jr, Yick J, Alpeter M, Welbourne TC, Ota DM.

Clin Chem. 1993 Jun;39(6):1059-63.

47.
48.

Feeding jejunostomy techniques.

Ota DM, Evans DB.

Surgery. 1993 May;113(5):598. No abstract available.

PMID:
8488485
49.

Substituting ornithine for arginine in total parenteral nutrition eliminates enhanced tumor growth.

Grossie VB Jr, Nishioka K, Ajani JA, Ota DM.

J Surg Oncol. 1992 Jul;50(3):161-7.

PMID:
1619938
50.

Laparoscopic feeding jejunostomy tube in oncology patients.

Ellis LM, Evans DB, Martin D, Ota DM.

Surg Oncol. 1992 Jun;1(3):245-9.

PMID:
1341257

Supplemental Content

Support Center